DEFA14A: Monogram Urges Shareholder Vote on Zimmer Biomet Merger

Monogram Technologies Inc. is actively soliciting stockholder votes for the upcoming special meeting on September 30, 2025, to approve its acquisition by Zimmer Biomet Holdings, Inc.

Summary

• Monogram Technologies Inc. has commenced distributing texts and emails to stockholders regarding the special meeting to approve its acquisition by Zimmer Biomet Holdings, Inc.
• The special meeting is scheduled for September 30, 2025, at 1:00 PM ET, and will be held online.
• Stockholders are asked to vote on two proposals: approving the Agreement and Plan of Merger for Zimmer Biomet to acquire Monogram, and approving the option to adjourn the meeting if more time is needed to collect votes.
• The Board of Directors unanimously recommends voting FOR both proposals.
• Voting instructions have been provided for both registered and street holders, including a dedicated voting website (monogram.vote) and contact information for a proxy solicitor, Okapi Partners LLC.

Sentiment

Score: 7

Explanation: The filing indicates a clear path forward for a previously announced acquisition, with the Board recommending approval. This suggests a positive sentiment regarding the completion of the merger, which is generally seen as a strategic positive for the company and its shareholders, assuming favorable terms.

Positives

• The Board of Directors unanimously recommends voting FOR the acquisition, indicating management's belief in the transaction's benefits.
• The company is actively engaging with stockholders to ensure participation in the crucial merger vote.

Risks

• The acquisition by Zimmer Biomet Holdings, Inc. requires stockholder approval, and failure to secure this approval could prevent the merger from proceeding.
• There is a potential need to adjourn the special meeting if insufficient votes are collected, which could delay the merger process.

Future Outlook

The future outlook for Monogram Technologies Inc. is contingent upon the approval of the acquisition by Zimmer Biomet Holdings, Inc. If approved, Monogram will be acquired, integrating its operations into Zimmer Biomet.

Management Comments

• The Board of Directors recommends voting FOR both proposals.
• Every vote counts!

Industry Context

This acquisition, if approved, would see Monogram Technologies, likely a player in healthcare technology or medical devices given Zimmer Biomet's profile, integrated into a larger, established medical device company. Such consolidations are common in the healthcare sector as larger entities seek to expand their product portfolios, technology capabilities, or market share through strategic acquisitions.

Corporate Governance

Stakeholder Impact

• Shareholders: Directly impacted by the merger vote, which will determine the future ownership and potential value realization of their shares. The Board's recommendation suggests a favorable outcome for shareholders.
• Employees: While not explicitly stated, a merger typically leads to integration efforts that can impact employee roles, compensation, and organizational structure.
• Management: The current management is actively soliciting votes for the merger, indicating their support for the transaction.

Next Steps

• Stockholders are urged to vote their shares on the merger proposals.
• The special meeting of stockholders will be held on September 30, 2025, to vote on the acquisition and the option to adjourn.
• If approved, the acquisition by Zimmer Biomet Holdings, Inc. will proceed.

Key Dates

Recommendation

The filing is a procedural update for a previously announced merger. The Board recommends approval, suggesting the merger is on track. For existing shareholders, the decision to hold or sell would likely depend on the merger terms (which are not detailed here) and their individual investment strategy relative to the acquisition price. For new investors, buying now would be speculative on the merger completion and its terms. Without the merger price, a 'hold' is a neutral stance, awaiting the outcome of the vote and the finalization of the transaction.

Keywords

Monogram Technologies, Zimmer Biomet, Acquisition, Merger, Stockholder Vote, Proxy Solicitation, MGRM, Healthcare Technology, Medical Devices